Fish health market leader STIM has been acquired by Summa Equity.
STIM is the aquaculture industry’s largest supplier of health products and services with revenues of more than €150 million in 2023.
“Aquaculture is one of the key building blocks in the sustainable food system of the future due to its low carbon footprint, scalability, and high feed efficiency,” said Martin Gjølme, partner at Summa.
“But as a young industry it faces challenges related to fish welfare and mortality. Solving these challenges through disease prevention, sound production protocols, genetics and nutrition will be key to unlock the industry’s full potential.”
STIM founder and chair Jim-Roger Nordly says the partnership is about driving growth, intensifying product development and expanding services.
“With Summa on our side, I am confident that STIM can become the world leader within sustainability and health, not just within the salmon industry, but for the seafood industry as a whole,” he said
“There is a huge demand for advisory services within this sector, and that is something we have our eyes on.”
The acquisition of STIM is being made by Summa Equity Fund III and contributes to UN Sustainable Development Goal 2.4 (‘Zero Hunger’ – sustainable food production) and 14.4 (‘Life Under Water’ - sustainable fishing).
